Abbott India Ltd Share Price
As on 19 November 2025 at 01:32 IST
Abbott India Q1 FY26 Results:
Profit for the period increased 12% to ₹366 crores in Q1 FY26, from ₹328 crores in Q1 FY25. Total income for the quarter increased 11% year-on-year to ₹1811 crores from ₹1625 crores.
About Abbott India Ltd
Abbott India Limited provides diagnostics solutions, medical devices, nutritional products, and pharmaceuticals. Founded in 1910, Abbott India has many years of experience in healthcare. This makes it a longstanding player in the industry. Its headquarters are located in Mumbai, Maharashtra. Main products include diagnostics solutions, medical devices, and pharmaceuticals. Abbott India operates in the healthcare sector. It is contributing significantly to the industry through its diverse product offerings and commitment to innovation and quality. The company also engages in corporate social responsibility initiatives. It supports community development programs and environmental sustainability projects. +
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-0.82%
Over 6 Months
-3.67%
Over 1 Year
8.73%
Over 3 Years
51.64%
Abbott India Ltd Summary
Close ₹29,560
Open ₹29,340
High ₹29,650
Low ₹29,180
Volume 8,689
Net Turnover (in Cr) ₹25.58
52Wk High ₹37,000
52Wk Low ₹25,325
52Wk High / Low
25,325
37,000
Abbott India Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹62,815
EPS (TTM) 710.09
Book Value (BV) 1,887.49
Div. Yield 1.60 %
P/E (TTM) 41.69
Price/Book Value 15.68
Delivery % 59.39 %
Face Value 10
Key Ratios
PE Ratio 46.17
PB Ratio 15.43
EV to Sales 9.91
PEG Ratio 2.60
ROA 31.09
ROE 35.66
Debt-Equity 0.04
Net Profit Margin 21.94
Operating Profit Margin 30.57
Abbott India Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 6,684.73 | 6,097.18 | 5,502.88 | 4,996.48 | 4,390.92 |
| Total Expenses | 4,797.78 | 4,479.43 | 4,229.06 | 3,916.75 | 3,464.97 |
| Profit Before Tax | 1,886.95 | 1,617.75 | 1,273.82 | 1,079.73 | 925.95 |
| Profit After Tax | 1,414.44 | 1,201.22 | 949.41 | 798.70 | 690.69 |
| Operating Profit After Depreciation | 1,898.38 | 1,630.20 | 1,289.81 | 1,098.83 | 944.23 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 335.98 | 224.94 | 236.91 | 271 | 250.78 |
| Total Non Current Assets | 1,175.72 | 1,947.65 | 1,530.40 | 371.08 | 353.04 |
| Total Current Assets | 4,741.59 | 3,245.84 | 3,025.11 | 3,853.04 | 3,487.41 |
| Total Assets | 5,917.31 | 5,193.49 | 4,555.51 | 4,224.12 | 3,840.45 |
| Total Shareholder's Fund | 4,233.15 | 3,698.89 | 3,188.54 | 2,819.79 | 2,602.16 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 1,011.84 | 1,212.81 | 893.39 | 947.66 | 726.74 |
| Net Cash Used In Investing Activities | 182.18 | -416.03 | -147.71 | -395.84 | -71.82 |
| Net Cash Used In Financing Activities | -925.17 | -744.71 | -638.72 | -637.38 | -581.79 |
No data available
| Particulars (in ₹ Cr.) | 2025-09 | 2025-06 | 2025-03 | 2024-12 | 2024-09 |
|---|---|---|---|---|---|
| Total Revenue | 1,757.15 | 1,738.35 | 1,604.59 | 1,614.28 | 1,632.67 |
| Total Expenses | 1,254.98 | 1,292.76 | 1,176.05 | 1,178.19 | 1,193.71 |
| Profit Before Tax | 545.93 | 493.13 | 482.71 | 487.59 | 479.43 |
| Profit After Tax | 415.27 | 365.86 | 367.04 | 360.78 | 358.61 |
| Operating Profit after Depreciation | 572.12 | 518.43 | 504.56 | 507.84 | 499.44 |
Abbott India Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 29,276.67
S2 28,993.33
S3 28,806.67
Pivot 29,463.33
R1 29,746.67
R2 29,933.33
R3 30,216.67
Moving Average
20 SMA 29,580.25
50 SMA 30,050.10
100 SMA 31,784.10
200 SMA 30,891.79
Abbott India Ltd Corporate Actions
Abbott India Ltd
₹475.0/Share
Announcement Date 25 Jul 2025
Record Date 25 Jul 2025
Div Yield 4750%
Abbott India Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,763.70 | ₹4,23,170.71 |
| Divis Laboratories Ltd | ₹6,523.25 | ₹1,73,171.79 |
| Torrent Pharmaceuticals Ltd | ₹3,816.75 | ₹1,29,170.36 |
| Cipla Ltd | ₹1,536.25 | ₹1,24,093.85 |
| Dr Reddys Laboratories Ltd | ₹1,244.50 | ₹1,03,868.61 |
Abbott India Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| SBI MNC Fund | 3.89% |
| SBI Innovative Opportunities Fund | 3.82% |
| SBI Healthcare Opportunities Fund | 2.84% |
| Nippon India Pharma Fund | 2.39% |
| SBI Large & Midcap Fund | 2.24% |
Abbott India Ltd News
Abbott India Q2 PAT jumps 16% YoY to Rs 415 cr
Abbott India's standalone net profit climbed 15.79% to Rs 415.27 crore on 7.62% increase in revenue from operations to Rs 1,757.15 crore in Q2 FY26 over Q2 FY25.
06 Nov 2025, 03:40 pm
Abbott India to hold board meeting
On 6 November 2025
30 Oct 2025, 10:39 am
Abbott India Ltd up for third straight session
Abbott India Ltd is quoting at Rs 30500, up 1.79% on the day as on 12:49 IST on the NSE. The stock is up 8.79% in last one year as compared to a 0.9% slide in NIFTY and a 5.5% slide in the Nifty Pharma index.
06 Oct 2025, 01:05 pm
Abbott India rises as Q1 PAT jumps 12% YoY to Rs 366 cr
Abbott India gained 1.61% to Rs 33,533.05 after the company's standalone net profit climbed 11.53% to Rs 365.86 crore on 11.60% increase in revenue from operations to Rs 1,738.35 crore in Q1 FY26 over Q1 FY25.
12 Aug 2025, 01:50 pm
Abbott India to hold board meeting
On 12 August 2025
05 Aug 2025, 02:43 pm
Abbott India Ltd Stock Analysis
- Annual revenue for Abbott India Ltd increased by 9.64% to ₹6,684.73 crore in FY 2025 from ₹6,097.18 crore in FY 2024.
- Annual Net Profit for Abbott India Ltd increased by 17.75% to ₹1,414.44 crore in FY 2025 from ₹1,201.22 crore in FY 2024.
- Promoter Shareholding in Abbott India Ltd remains unchanged by 0.00% in the most recent quarter, from 74.99% in June 2025 to 74.99% in September 2025.
- Abbott India Ltd delivered a 1-year return of 8.73% compared to the Nifty 50, which provided a return of 10.91% as of the last trading session.
- Abbott India Ltd share price moved up by 0.47% from its previous close of INR ₹29,560. The latest Abbott India Ltd share price is INR ₹29,700.
- Abbott India Ltd share price today has been at a low of 29,470 and a high of 29,730. Over the past 52 weeks, the Abbott India Ltd share price has seen a low of 25,325 and a high of 37,000.
About Abbott India Ltd
Abbott India Limited is a leading healthcare company. It offers a diverse range of diagnostics solutions and medical devices. The company also offers nutritional products and established pharmaceuticals. Established in 1910, Abbott India has a rich history of many decades in the healthcare sector. The company’s headquarters are located in Mumbai, Maharashtra, India.
The company is a subsidiary of Abbott Laboratories, an American healthcare giant. Abbott India benefits from a global network of expertise and innovation. The company provides products across various therapeutic categories. This includes women’s health and gastroenterology. It also includes cardiology, metabolic disorders, and primary care. Its main offerings include diagnostics solutions and medical devices. Along with that, it offers nutritional products and a range of pharmaceuticals.
It is a significant player in the healthcare sector. It holds a considerable position in the Indian healthcare market. Its success is driven by its commitment to quality and innovation. Abbott Laboratories, the parent company, holds a significant shareholding in Abbott India at 74.99%. This fact underscores the strategic importance of the Indian market to its global operations. Here are the primary promoters of the company:
The company’s journey began with a commitment to providing high-quality healthcare solutions to the Indian market. Abbott India has grown significantly over the years, becoming a key player in the Indian healthcare industry. The company offers products across various therapeutic categories. This includes women’s health, gastroenterology and cardiology. It also provides products for metabolic disorders and primary care. Its main products include diagnostics solutions and medical devices. The list also includes nutritional products and a range of pharmaceuticals.
Abbott India’s mission is to help people live healthier lives by providing reliable and innovative healthcare solutions. The company’s products are known for their quality and efficacy. They play a crucial role in improving health outcomes for millions of people in India. Abbott India’s commitment to excellence is reflected in its robust product development. It is also evident in the company’s manufacturing, sales, and customer service processes.
A dedicated Board of Directors guides the company’s leadership team. They ensure that Abbott India continues to uphold its high standards of quality and innovation. The management team includes experienced professionals who are passionate about making a positive impact on healthcare in India.
Abbott India’s registered office is located at Sion Trombay Road, Mumbai, Maharashtra 4000714. Abbott India Limited was incorporated initially as Boots Pure Drug Company (India) Limited on August 22, 1944. It has a rich history of many decades. The company underwent several name changes, becoming The Boots Company (India) Limited in 1971. It finally adopted its current name, Abbott India Limited, on July 1, 2002. Abbott India is a subsidiary of Abbott Laboratories, an American healthcare giant. It is headquartered in Mumbai, Maharashtra.
Over the years, Abbott India has expanded its product portfolio to include diagnostics solutions, medical devices and nutritional products. The portfolio also includes pharmaceuticals across various therapeutic categories. The company’s commitment to quality and innovation has made it a trusted name in the Indian healthcare market. Abbott India’s extensive research and development efforts ensure that it stays at the forefront of medical advancements. It is continually improving its offerings to serve the healthcare needs of the community better.
A dedicated Board of Directors leads Abbott India’s leadership team. They play a crucial role in guiding the company’s strategic direction and maintaining its high standards. The management team comprises experienced professionals who are passionate about making a positive impact on healthcare in India. Their collective expertise and commitment to excellence drive Abbott India’s success and growth. Abbott India continues to be a leading force in the Indian healthcare industry. It is dedicated to improving health outcomes and enhancing the quality of life for millions of people.
Abbott India Limited has a rich history of many years, marked by its commitment to providing high-quality healthcare solutions. As a subsidiary of Abbott Laboratories, the company continues to play a vital role in the Indian healthcare market. It continues to contribute to improved health outcomes and well-being for millions of people.
The company is a subsidiary of Abbott Laboratories, an American healthcare giant. Abbott India benefits from a global network of expertise and innovation. The company provides products across various therapeutic categories. This includes women’s health and gastroenterology. It also includes cardiology, metabolic disorders, and primary care. Its main offerings include diagnostics solutions and medical devices. Along with that, it offers nutritional products and a range of pharmaceuticals.
It is a significant player in the healthcare sector. It holds a considerable position in the Indian healthcare market. Its success is driven by its commitment to quality and innovation. Abbott Laboratories, the parent company, holds a significant shareholding in Abbott India at 74.99%. This fact underscores the strategic importance of the Indian market to its global operations. Here are the primary promoters of the company:
- Munir Shaikh
- Swati Dalal
- Kaiyomarz Marfatia
- Ambati Venu
- Sabina Ewing
Background of the Company
Abbott India Limited was established in 1910. It is one of the oldest and most respected healthcare companies in India. Headquartered in Mumbai, Maharashtra, Abbott India is a subsidiary of Abbott Laboratories, an American healthcare giant. Over the past many years, Abbott India has been dedicated to improving health and well-being. They do this through diverse science-based nutritional products and diagnostic tools. It also provides branded generic pharmaceuticals, and diabetes and vascular devices.The company’s journey began with a commitment to providing high-quality healthcare solutions to the Indian market. Abbott India has grown significantly over the years, becoming a key player in the Indian healthcare industry. The company offers products across various therapeutic categories. This includes women’s health, gastroenterology and cardiology. It also provides products for metabolic disorders and primary care. Its main products include diagnostics solutions and medical devices. The list also includes nutritional products and a range of pharmaceuticals.
Abbott India’s mission is to help people live healthier lives by providing reliable and innovative healthcare solutions. The company’s products are known for their quality and efficacy. They play a crucial role in improving health outcomes for millions of people in India. Abbott India’s commitment to excellence is reflected in its robust product development. It is also evident in the company’s manufacturing, sales, and customer service processes.
A dedicated Board of Directors guides the company’s leadership team. They ensure that Abbott India continues to uphold its high standards of quality and innovation. The management team includes experienced professionals who are passionate about making a positive impact on healthcare in India.
Abbott India’s registered office is located at Sion Trombay Road, Mumbai, Maharashtra 4000714. Abbott India Limited was incorporated initially as Boots Pure Drug Company (India) Limited on August 22, 1944. It has a rich history of many decades. The company underwent several name changes, becoming The Boots Company (India) Limited in 1971. It finally adopted its current name, Abbott India Limited, on July 1, 2002. Abbott India is a subsidiary of Abbott Laboratories, an American healthcare giant. It is headquartered in Mumbai, Maharashtra.
Over the years, Abbott India has expanded its product portfolio to include diagnostics solutions, medical devices and nutritional products. The portfolio also includes pharmaceuticals across various therapeutic categories. The company’s commitment to quality and innovation has made it a trusted name in the Indian healthcare market. Abbott India’s extensive research and development efforts ensure that it stays at the forefront of medical advancements. It is continually improving its offerings to serve the healthcare needs of the community better.
A dedicated Board of Directors leads Abbott India’s leadership team. They play a crucial role in guiding the company’s strategic direction and maintaining its high standards. The management team comprises experienced professionals who are passionate about making a positive impact on healthcare in India. Their collective expertise and commitment to excellence drive Abbott India’s success and growth. Abbott India continues to be a leading force in the Indian healthcare industry. It is dedicated to improving health outcomes and enhancing the quality of life for millions of people.
Abbott India Limited has a rich history of many years, marked by its commitment to providing high-quality healthcare solutions. As a subsidiary of Abbott Laboratories, the company continues to play a vital role in the Indian healthcare market. It continues to contribute to improved health outcomes and well-being for millions of people.
FAQ’s
What is the share price of Abbott India Ltd today?
Abbott India Ltd share price as on 18 Nov 2025 is ₹ 29700.0
What is the Market Cap of Abbott India Ltd?
The market cap of Abbott India Ltd stock is ₹62,815 Cr.
What is the PE Ratio of Abbott India Ltd?
The Price to Earnings (P/E) Ratio of Abbott India Ltd is 46.17
What is the PB Ratio of Abbott India Ltd?
The Price to Book (P/B) Ratio of Abbott India Ltd is 15.43
What is the 52 week high of Abbott India Ltd Share Price?
The 52 week high of Abbott India Ltd share price stands at ₹37,000
What is the 52 week low of Abbott India Ltd Share Price?
The 52 week low of Abbott India Ltd share price stands at ₹25,325
How can I buy shares of Abbott India Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Abbott India Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
